They were not able to vote because they did not have any electors to represent them.
Answer:
For depriving us in many cases, of the benefits of Trial by Jury
Explanation:
From quizlet
Under the HITECH Act of 2009, the privacy protections of HIPAA were strengthened and significantly expanded.
<h3>
What was the HITECH Act of 2009?</h3>
- The Health Information Technology for Economic and Clinical Health (HITECH) Act was signed into law on February 17, 2009, as part of the American Recovery and Reinvestment Act of 2009.
- Its purpose is to promote the adoption and meaningful use of health information technology.
- The HITECH Act of 2009 broadened the scope of privacy and security safeguards available through HIPAA compliance by increasing the potential legal liability for noncompliance and mandating more stringent enforcement.
- The HITECH Act transformed how many healthcare facilities generate, use, share, and maintain healthcare data.
- According to a 2016 report to Congress by the National Coordinator for Health Information Technology, it improved patient safety and resulted in better patient outcomes.
Therefore, under the HITECH Act of 2009, the privacy protections of HIPAA were strengthened and significantly expanded.
Know more about the HITECH Act of 2009 here:
brainly.com/question/15058159
#SPJ4
Answer:
Sara is illustrating a relational message.
Explanation:
Communication can be divided into categories referring to content or to relation. The content of a message refers to its subject. The relational part of a message refers to the existing relationship between the people communicating. It can be verbal or non-verbal, and is influenced by affinity, respect, control etc. Sara is expressing respect through non-verbal communication. Her gestures and actions convey that she values her boss and what he/she says.
Answer:
<em><u>The answer is</u></em>: <u>They not only serve for Regenerative Medicine, but also for the "screening" of new drugs, and some other things.</u>
Explanation:
Currently, studies in regenerative medicine are aimed at research and knowledge of induced pluripotent cells (iPSCs). For some, they are the cells called to take over from embryonic stem cells (ESCs), which until recently were the main objective of research in this field of biomedicine.
<u>Since the first cultures of mouse embryonic cells derived from blastocysts were obtained in 1981</u>, the foundations were laid for the development of the necessary methodologies that would lead later to generate human embryonic cells with characteristics similar to those of the mouse.
In addition to their interest in Regenerative Medicine, these types of cells are a tool of great value for the "screening" of new drugs, as well as a model to study the etiology of diseases that originate during the embryonic stage, and to study processes that occur during human embryonic development
.
<em><u>The answer is</u></em>: <u>They not only serve for Regenerative Medicine, but also for the "screening" of new drugs, and some other things.</u>